HEC Management GP LLC

CIK 1700567 · last filed 2020-05-11

HEC Management GP LLC is a corporate insider who has filed 14 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing, for TVTY, was dated May 11, 2020. Across all open-market trades the lifetime net is +$53.0M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 49 SEC filings were submitted jointly with Hudson Executive Capital LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
14
Lifetime Open-Market Net
$53.02M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CATM price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
1185 AVENUE OF THE AMERICAS, 32ND FLOOR
NEW YORK, NY 10036
Phone
(212) 521-8495
State of Incorporation
DE
Related Filers
Hudson Executive Capital LP — 49 joint filings, latest 2024-02-21
Douglas L Braunstein — 46 joint filings, latest 2024-02-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TIVITY HEALTH, INC. (TVTY) Delisted 10%+ Owner 4,795,310 $32.50 $155.85M $0 1 2020-05-11
Cardtronics plc (CATM) Delisted Director 8,135,021 $39.01 $317.35M $55.75M 5 2020-03-11
CANTALOUPE, INC. (USAT) Delisted 10%+ Owner — $12.16 — $0 1 2020-03-06
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Director 732,777 $2.14 $1.57M -$12.64M 5 2019-10-28
CANTALOUPE, INC. (USATP) Delisted 10%+ Owner 8,339,172 — — $1.92M 1 2019-09-23
Corindus Vascular Robotics, Inc. (CVRS) Delisted 10%+ Owner 14,235,545 — — $8.00M 1 2019-03-14

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-05-11 TIVITY HEALTH, INC. (TVTY) Delisted Mixed −11,880,000 -$144.94M EDGAR
2020-03-11 Cardtronics plc (CATM) Delisted Exer (M) +12,834 $0 EDGAR
2020-03-06 CANTALOUPE, INC. (USAT) Delisted Sell (S) — $0 EDGAR
2019-10-28 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −50,793 -$3.22M EDGAR
2019-10-18 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −46,632 -$2.92M EDGAR
2019-10-15 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −84,114 -$5.10M EDGAR
2019-10-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −19,377 -$1.16M EDGAR
2019-09-23 CANTALOUPE, INC. (USATP) Delisted Buy (P) +429,600 $1.92M EDGAR
2019-09-13 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −3,936 -$236.4K EDGAR
2019-03-14 Corindus Vascular Robotics, Inc. (CVRS) Delisted Buy (P) +5,798,782 $8.00M EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.